Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis (2014)
- Autores:
- Autores USP: DUARTE, ALBERTO JOSE DA SILVA - FM ; BENARD, GIL - FM
- Unidade: FM
- DOI: 10.2340/00015555-1650
- Assuntos: PSORÍASE; DERMATOLOGIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Acta dermato-venereologica
- ISSN: 0001-5555
- Volume/Número/Paginação/Ano: v. 94, n. 1, p. 26-31, 2014
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
ORTIGOSA, Luciena C. M. et al. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, v. 94, n. 1, p. 26-31, 2014Tradução . . Disponível em: https://doi.org/10.2340/00015555-1650. Acesso em: 26 abr. 2024. -
APA
Ortigosa, L. C. M., Silva, L. C. R., Duarte, A. J. S., Takahashi, M. D. F., & Bebrad, G. (2014). Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, 94( 1), 26-31. doi:10.2340/00015555-1650 -
NLM
Ortigosa LCM, Silva LCR, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2024 abr. 26 ] Available from: https://doi.org/10.2340/00015555-1650 -
Vancouver
Ortigosa LCM, Silva LCR, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2024 abr. 26 ] Available from: https://doi.org/10.2340/00015555-1650 - The role of interleukin-10 in the differential expression of interleukin-12p70 and its beta2 receptor on patients with active or treated paracoccidioidomycosis and healthy infected subjects
- Analysis of the expression of costimulatory molecules by T cells from paracoccidioidomycosis patients
- Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test
- Disseminated intracellular infections in a patient with myeloperoxidase deficiency
- Imbalance of IL-2, IFN-'fi' and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis
- Proliferative response to GP43, periodated GP43, and P. brasiliensis culture antigens in patients with or cured of paracoccidioidomycosis
- Immune restoration against mycobacterium tuberculosis in aids patients receiving long-term highly active antiretroviral therapy
- Differential expression of the costimulatory molecules CD86, CD28, CD152 and PD-1 correlates with the host-parasite outcome in leprosy
- Evalution of phagocytosis of P. brasiliensis in dendritic cells of patients with paracoccidiodomycosis and helthy individuals
- Susceptibility or resistance to human paracoccidioidomycosis is not linked to defects in iNKT cells
Informações sobre o DOI: 10.2340/00015555-1650 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
